bioRxiv Science⌕ Search

Biology subjects

Sham, P. C.

Publications and source records attributed to Sham, P. C..

At least 19 recordsLinked to original sources

A genomic foundation model for interpreting human genetic diversity

Interpreting human genomes requires models that recognize shared biological functions while accounting for variation underlying traits, disease susceptibility and adaptation. Here we present hEVO, a genomic foundation model trained on 4.784 billion distinct haplotype sequences reconstructed from whole genome sequencing (WGS) data for 63,809 individuals selected from 550,237 samples across eight cohorts. Pretraining integrates shared sequence features and naturally occurring allelic differences without clinical or functional labels. Against representatives of the Evo 2, NT, GPN and other genomic model families, hEVO ranked first in 18 of 19 primary comparisons spanning functional annotation, variant interpretation and human evolution. Its pretrained allele scores generalized across all six complementary variant benchmarks without task-specific training, achieving the highest performance across clinical pathogenicity, fine-mapped causal variants and experimentally measured regulatory effects. Retrospective ClinVar reclassification further demonstrated improved identification of pathogenic classifications later downgraded, supporting reassessment of earlier clinical interpretations. Predictive strengths extended to ancestry inference, human accelerated sequences and preference for reported selected alleles. This breadth was achieved with substantially fewer parameters than billion-parameter comparators and low inference overhead in the evaluated workloads. These findings establish human haplotype diversity as a source of transferable biological information for interpreting both the disruption of genome function and the variation retained during human evolution.

genomics↗

Single-cell multiomic QTL mapping reveals state-dependent genetic regulation and associated gene during cellular senescence

How cellular senescence reshapes inherited regulatory effects across chromatin and transcription, and eventually contribute to non-coding risk loci of complex diseases, remains elusive. We generated single-cell multiome ATAC-RNA profiles from proliferating and replicatively senescent primary HUVECs derived from 100 genotyped donors. Alongside state-resolved eQTL and caQTL mapping, we implemented covariance-aware multivariate QTL mapping to identify chromatin accessibility-expression QTLs (caeQTLs), modeling accessibility and expression as a joint phenotype. Joint analysis recovered moderate, asymmetric and modality-distributed associations missed by single-modality scans, revealed senescence-associated regulatory programs, and prioritized candidate causal variants and effector genes at cardiovascular loci. Fine-mapping, chromatin-state annotation and heritability enrichment, together with independent SNP-to-gene algorithms, provided convergent orthogonal support. Mechanistic dissection revealed that rs2019090 modulates PDGFD expression and endothelial phenotypes through senescence-amplified, allele-specific, HMGA1-associated enhancer-promoter regulation. This study establishes senescence-resolved joint multiomic QTL mapping as a framework for narrowing the missing regulation gap in complex disease genetics.

genetics↗

Stratifying variant deleteriousness and trait-modulating effect under human recent adaptation

Despite advances in annotating and interpreting human genetic variants, existing methods to distinguish deleterious/pathogenic from neutral variants still inadequately capture the nuanced impact of genetic variants on fitness and disease susceptibility. In this study, we introduced a new deep learning framework, the FIND model, by stratifying genetic variants into refined categories based on selection pressures and derived allele frequency. FIND demonstrated superior performance over existing genome-wide methods, delivering enhanced resolution in differentiating trait-modulating alleles from those that are pathogenic or neutral. Access to base-wise informative annotations has unveiled novel features that significantly enhance the model interpretability, and FIND has adeptly delineated evolutionary trends in human accelerated regions. Furthermore, applying FIND to the interpretation of clinical variants demonstrates its substantial potential in reclassifying variants of unknown significance. This work advances our understanding of the genetic underpinnings of human adaptation and disease, providing a new tool to explore the complexities of genetic contributions to health.

genetics↗

Endogenous fine-mapping of functional regulatory elements in complex genetic loci

The vast majority of genetic loci associated with polygenic complex traits are located in non-coding regions of the human genome. However, many of these regions exhibit high- order gene regulatory relationships and complicated linkage disequilibrium (LD) configurations, which bring challenges to accurately identify causal variants and their target genes controlling specific molecular processes or traits. We employed multiplexed single-cell CRISPR interference and activation perturbations to explore the links between cis-regulatory element (CRE) and target gene expression within tight LD in the endogenous chromatin context. We validated the prevalence of multiple causality in perfect LD (pLD) for independent expression quantitative trait locus (eQTL), and revealed fine-grained genetic effects on gene expression within pLD. These effects are difficult to decipher using conventional eQTL fine-mapping or to predict via existing computational methods. We found that nearly half of the casual CREs lack classical epigenetic markers, potentially affecting gene expression through hidden regulatory mechanisms. Integrative analysis on different types of perturbation effects suggested a high regulatory plasticity of the human genome. These findings will propel further in-depth exploration of functional genomic elements, facilitating a more comprehensive understanding of gene expression regulatory patterns and the development of complex traits.

genomics↗

INSIDER: Interpretable Sparse Matrix Decomposition for Bulk RNA Expression Data Analysis

RNA-Seq is widely used to capture transcriptome dynamics across tissues from different biological entities even across biological conditions, with the aim of understanding the contribution of gene activities to phenotypes of biosamples. However, due to variation from tissues and biological entities (or other biological conditions), joint analysis of bulk RNA expression profiles across multiple tissues from a number of biological entities to achieve the aim is hindered. Moreover, it is crucial to consider interactions between biological variables. For example, different brain disorders may affect brain regions heterogeneously. Thus, modeling the disorder-region interaction can shed light on the heterogeneity. To address these key challenges, we propose a general and flexible statistical framework based on matrix factorization, named INSIDER (https://github.com/kai0511/insider). INSIDER decomposes variation from different biological variables into a shared low-rank latent space. In particular, it considers interactions between biological variables and introduces the elastic net penalty to induce sparsity, thus facilitating interpretation. In the framework, the biological variables and interaction terms can be defined based on the research questions and study design. Besides, it enables us to compute the adjusted expression profiles for biological variables that control variation from other biological variables. Lastly, it allows various downstream analyses, such as clustering donors with donor representations, revealing development trajectory in its application to the BrainSpan data, and uncovering mechanisms underlying variables like phenotype and interactions between biological variables (e.g., phenotypes and tissues).

bioinformatics↗

Inferring CTCF insulators and anchored loops across human tissues and cell types

CCCTC-binding factor (CTCF) is a transcription regulator which is involved in many cellular processes. How CTCF recognizes DNA sequence to exert chromosome barrier or enhancer blocking effects remains to be fully interrogated. Despite many computational tools were developed to predict CTCF-mediated loops qualitatively or quantitatively, few could specially evaluate the regulatory potential of DNA sequence at CTCF binding sites (CBSs) and how it affects chromatin loop formation. Here, we developed a deep learning model, DeepAnchor, to precisely characterize the binding patterns for different types of CBSs. By incorporating base-wise genomic/epigenomic features, we revealed distinct chromatin and sequence features for CTCF-mediated insulation and looping at a high resolution, such as two sequence motifs flanking the core CTCF motif at loop-associated CBSs. Besides, we leveraged the predicted anchor score to optimize the loop extrusion model and achieved the best performance in predicting CTCF-anchored loops. We established a compendium of context-specific CTCF-anchored loops across 52 human tissue/cell types and found that genomic disruption of CTCF-anchored loops may represent a general causal mechanism of disease pathogenesis. These computational models, together with the established resource, could facilitate the mechanistic research on how the CTCF-mediated cis-regulatory elements (CREs) shapes context-specific gene regulation in cell development and disease progression.

bioinformatics↗

Sex-Dependent Shared and Non-Shared Genetic Architecture Across Mood and Psychotic Disorders

BACKGROUNDSex differences in incidence and/or presentation of schizophrenia (SCZ), major depressive disorder (MDD), and bipolar disorder (BIP) are pervasive. Previous evidence for shared genetic risk and sex differences in brain abnormalities across disorders suggest possible shared sex-dependent genetic risk. METHODSWe conducted the largest to date genome-wide genotype-by-sex (GxS) interaction of risk for these disorders, using 85,735 cases (33,403 SCZ, 19,924 BIP, 32,408 MDD) and 109,946 controls from the Psychiatric Genomics Consortium (PGC) and iPSYCH. RESULTSAcross disorders, genome-wide significant SNP-by-sex interaction was detected for a locus encompassing NKAIN2 (rs117780815; p=3.2x10-8), that interacts with sodium/potassium-transporting ATPase enzymes implicating neuronal excitability. Three additional loci showed evidence (p<1x10-6) for cross-disorder GxS interaction (rs7302529, p=1.6x10-7; rs73033497, p=8.8x10-7; rs7914279, p=6.4x10-7) implicating various functions. Gene-based analyses identified GxS interaction across disorders (p=8.97x10-7) with transcriptional inhibitor SLTM. Most significant in SCZ was a MOCOS gene locus (rs11665282; p=1.5x10-7), implicating vascular endothelial cells. Secondary analysis of the PGC-SCZ dataset detected an interaction (rs13265509; p=1.1x10-7) in a locus containing IDO2, a kynurenine pathway enzyme with immunoregulatory functions implicated in SCZ, BIP, and MDD. Pathway enrichment analysis detected significant GxS of genes regulating vascular endothelial growth factor (VEGF) receptor signaling in MDD (pFDR<0.05). CONCLUSIONSIn the largest genome-wide GxS analysis of mood and psychotic disorders to date, there was substantial genetic overlap between the sexes. However, significant sex-dependent effects were enriched for genes related to neuronal development, immune and vascular functions across and within SCZ, BIP, and MDD at the variant, gene, and pathway enrichment levels.

genetics↗

Modeling Parent-Specific Genetic Nurture in Families with Missing Parental Genotypes: Application to Birthweight and BMI

Disaggregation and estimation of genetic effects from offspring and parents has long been of interest to statistical geneticists. Recently, technical and methodological advances have made the genome-wide and loci-specific estimation of direct offspring and parental genetic nurture effects more possible. However, unbiased estimation using these methods requires datasets where both parents and at least one child have been genotyped, which are relatively scarce. Our group has recently developed a method and accompanying software (IMPISH; Hwang et al., 2020) which is able to impute missing parental genotypes from observed data on sibships and estimate their effects on an offspring phenotype conditional on the effects of genetic transmission. However, this method is unable to disentangle maternal and paternal effects, which may differ in magnitude and direction. Here, we introduce an extension to the original IMPISH routine which takes advantage of all available nuclear families to impute parent-specific missing genotypes and obtain asymptotically unbiased estimates of genetic effects on offspring phenotypes. We apply this this method to data from related individuals in the UK Biobank, showing concordance with previous estimates of maternal genetic effects on offspring birthweight. We also conduct the first GWAS jointly estimating offspring-, maternal-, and paternal-specific genetic effects on body mass index.

genetics↗

Deviation from baseline mutation burden provides powerful and robust rare-variants association test for complex diseases

The identification of rare variants that contribute to complex diseases is challenging due to low statistical power. Here we propose a novel and powerful rare variants association test based on the deviation of the observed mutational burden in a genomic region from a baseline mutation burden predicted by weighted recursive truncated negative-binomial regression (RUNNER) on genomic features available from public data. Simulation studies show that RUNNER is substantially more powerful than state-of-the-art rare variant association methods (including SKAT, CMC and KBAC), while maintaining correct type 1 error rates under population stratification and in small samples. Applied to real data, RUNNER “rediscovered” known genes of Hirschsprung disease missed by current methods, and detected promising new candidate genes, including NXPE4 for Hirschsprung disease and CXCL16 for Alzheimer’s disease. The proposed approach provides a powerful and robust method to identify rare risk variants for complex diseases.Competing Interest StatementThe authors have declared no competing interest.View Full Text

genetics↗

Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity that may underly population disparities in this disease

Systemic lupus erythematosus (SLE), a worldwide autoimmune disease with high heritability, shows differences in prevalence, severity and age of onset among different ancestral groups. Previous genetic studies have focused more on European populations, which appear to be the least affected. Consequently, the genetic variations that underly the commonalities, differences and treatment options in SLE among ancestral groups have not been well elucidated. To address this, we undertook a genome-wide association study, increasing the sample size of Chinese populations to the level of existing European studies. Thirty-eight novel SLE-associated loci and incomplete sharing of genetic architecture were identified. Nine disease loci showed clear ancestral group heterogeneity and implicated antibody production as a potential mechanism for differences in disease manifestation. Polygenic risk scores performed significantly better when trained on matched ancestral data sets. These analyses help to reveal the genetic bases for disparities in SLE among ancestral groups.

genetics↗

Estimating indirect parental genetic effects on offspring phenotypes using virtual parental genotypes derived from sibling and half sibling pairs

Indirect parental genetic effects may be defined as the influence of parental genotypes on offspring phenotypes over and above that which results from the transmission of genes from parents to children. However, given the relative paucity of large-scale family-based cohorts around the world, it is difficult to demonstrate parental genetic effects on human traits, particularly at individual loci. In this manuscript, we illustrate how parental genetic effects on offspring phenotypes, including late onset diseases, can be estimated at individual loci in principle using large-scale genome-wide association study (GWAS) data, even in the absence of parental genotypes. Our strategy involves creating "virtual" mothers and fathers by estimating the genotypic dosages of parental genotypes using physically genotyped data from relative pairs. We then utilize the expected dosages of the parents, and the actual genotypes of the offspring relative pairs, to perform conditional genetic association analyses to obtain asymptotically unbiased estimates of maternal, paternal and offspring genetic effects. We develop a freely available web application that quantifies the power of our approach using closed form asymptotic solutions. We implement our methods in a user-friendly software package IMPISH (IMputing Parental genotypes In Siblings and Half-Siblings) which allows users to quickly and efficiently impute parental genotypes across the genome in large genome-wide datasets, and then use these estimated dosages in downstream linear mixed model association analyses. We conclude that imputing parental genotypes from relative pairs may provide a useful adjunct to existing large-scale genetic studies of parents and their offspring.

genetics↗

Cytokines and schizophrenia revisited: a two-sample multi-marker Mendelian randomization approach

BackgroundSchizophrenia is a complex mental disorder with recent evidence suggesting a critical immune component underpinning its pathophysiology. Two-sample Mendelian randomization (MR) provided an opportunity to probe the immune changes in schizophrenia by harnessing the increasing availability of summary-level data from large GWAS consortia. ObjectiveTo map the extensive immune response of schizophrenia in terms of cytokines/chemokines and to explore the effect of cytokines induced by schizophrenia (SCZ-induced cytokines) on the brain structure and function Sources and methodsUsing the summary-level data generated from GWAS of schizophrenia, cytokines in the peripheral blood and imaging-derived phenotypes (IDPs), we performed two rounds of two-sample MR analysis; the identified cytokines from first round of analysis (schizophrenia => cytokines) were modeled for its underlying structure and subsequent clustering analysis further grouped SCZ-induced cytokines based on their genetic similarities. The multi-phenotype summary statistics of each cytokine module were then used as instrumental variables (IVs) for the second round of MR analysis to detect their effect on brain structure and function. ResultsThe first round of MR analysis identified nine cytokines, the highlight of which includes IL18 (OR = 1.292, P = 8.37 x 10-42) and TNFa (OR = 0.721, P = 7.33 x 10-6), to be causally associated with schizophrenia. These SCZ-induced cytokines could be clustered into three modules. The second round of MR analysis (cytokine module => IDPs) indicated that module B (SCGFb-IP10-CTACK-IL6) significantly increased the level of IDPs including IDP_T1_SIENAX_peripheral_grey_normalised_volume ({beta} = 0.0453, P = 4.40x1010), IDP_dMRI_TBSS_MD_Posterior_corona_radiata_R ({beta}= 0.0584, P = 8.89x 10-16) and IDP_dMRI_TBSS_MD_Cingulum_hippocampus_R ({beta} = 0.0563, P = 9.88x 10-15), with module C (IL18-GROa-TNFa) increasing the level of IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_R ({beta}= 0.0341, P = 2.67x 10-6). ConclusionOur study, for the first time, mapped the causal link from schizophrenia to the comprehensive immune responses, and the findings suggest immune networks play a role in pathophysiology of schizophrenia by mediating the deviations of total gray matter volume and white matter fibers possibly in the mesolimbic system.

bioinformatics↗

The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control analysis from the EUGEI study.

Background: Some recent studies have challenged the direction of causality for the association between cannabis use and psychotic disorder, suggesting that cannabis use initiation is explained by common genetic variants associated with risk of schizophrenia. We used data from the European Union Gene-Environment Interaction consortium (EUGEI) case-control study to test for the independent and combined effect of heavy cannabis use, and of Schizophrenia Polygenic risk score (SZ PRS), on risk for psychotic disorder. Methods: Genome-wide data were obtained from 492 first episode psychosis patients (FEPp) and from 787 controls of European Ancestry, and used to generate SZ PRS from the summary results of an independent meta-analysis. Information on pattern of cannabis use was used to build a 7-level frequency-type composite cannabis use measure that we previously found was a strong predictor of psychotic disorder. Results: SZ PRS did not predict cannabis initiation (b=0.027; p=0.51) or how frequently controls (b=0.027; p=0.06) or FEPp (b=0.006; p=0.91) used it, or the type of cannabis they used (Controls: b = 0.032; p=0.31); FEPp: b= 0.005; p=0.89). The frequency-type composite cannabis use measure (OR=1.32; 95% CI 1.22-1.44) and SZ PRS (OR=2.29; 95%CI 1.71-3.05) showed independent effects from each other on the OR for psychotic disorder. Conclusion: SZ PRS does not predict an individual s propensity to try cannabis, frequency of use, or the potency of the cannabis used. Our findings provide the first evidence that SZ PRS and heavy cannabis use exert effects independent from each other on the risk for psychotic disorder.

genetics↗

Spatial expression pattern of ZNF391 gene in the brains of patients with schizophrenia, bipolar disorders or major depressive disorder identifies new cross-disorder biotypes: A trans-diagnostic, top-down approach

BackgroundGiven the struggle in the field of psychiatry to realize the precise diagnosis and treatment, it is in an urgent need to redefine psychiatric disorders based on objective biomarkers. The results generated from large psychiatric genomic consortia show us some new vantage points to understand the pathophysiology of psychiatric disorders. Nevertheless, how to relate these captured signals to the more refined disease dimensions has yet to be established.\n\nMethodsWe chose a top-down, cross-disorder approach by using the summary statistics of GWAS from large psychiatric genomic consortia to build a genomic structural equation model (SEM) for SCZ, BD and MDD to detect their common factor (CF), and to map a potential causal core gene for the CF, followed by the transcriptional prediction of the identified causal gene in our sample and the discovery of new biotypes based on the prediction pattern of the causal gene in the brain. We then characterized the biotypes in the context of their demographic features, cognitive functions and neuroimaging traits.\n\nOutcomesA common factor emerged from a well-fitting genomic SEM of SCZ, BD and MDD (loading 0.42, 0.35 and 0.09 for SCZ, BD and MDD, respectively). One genomic region in chromosome 6 was implicated in the genetic make-up of the common factor, with fine-mapping analysis marking ZNF391 as a potential causal core gene (posterior possibility = 0.96). Gene expression inference analysis identified eight brain regions showing different expression levels of ZNF391 between patients and controls, with three biotypes arising from clustering patients based on their expression pattern of ZNF391 in the brain. The three biotypes performed significantly differently in working memory (PDMS_TC = 0.015, PDMS_TC_A = 0.0318, PDMS_t0D = 0.015) and demonstrated different gray matter volumes in right inferior frontal orbital gyrus (RIFOG) in the same order as working memory (biotype 3 > biotype 2 > biotype 1, PRIFOG = 0.0027). Using ZNF391 as instrumental variable (IV), a partial casual path could be linked from RIFOG to working memory ({beta}RIFOG->DMS_TC0D = 4.95, P = 0.0056; {beta} RIFOG->DMS_TC = 2.53, P = 0.059; {beta}RIFOG->DMS_TC_A = 2.57, P = 0.056).\n\nInterpretationThe general predisposition to several psychiatric disorders may be influenced by variations of ZNF391, through its effects on right inferior frontal orbital gyrus and working memory. This illustrates the potential of a trans-diagnostic, top-down approach in understanding the commonality of psychiatric disorders.\n\nEvidence before this studyThe results from recent cross-disorder genome-wide association studies (GWAS)using large samples indicate that there is notable genetic overlapping between psychiatric disorders. However, the structural relationship of these disorders at the genomic level and the details of refined disease dimensions affected by the associated loci in a cross-disorder pattern remains unknown. We searched the published studies (up to Sep 7, 2019) in PubMed using the combination of the following keywords \"((cross disorder) OR (schizophrenia AND bipolar disorder AND major depressive disorder) AND (genome AND structural equation) AND (cognition OR imaging))\", no published study was found. We then removed the term \"structural equation\", 23 original studies were found. To the best of our knowledge, none of these studies explored the organized structure between three disorders. Further, of 23 articles we found, the majority of them took an approach of either polygenic risk score (PRS) or candidate gene to test the association with either psychological traits such as loneliness or neuroimaging measures in one (schizophrenia) or two (schizophrenia and bipolar) disorders. Hitherto, no study has been conducted to redefine three disorders based on the biological markers generated from the cross-disorder genomic studies.\n\nAdded value of this studyAdopting a novel approach of genomic structural equation modelling, we used the latest results of GWAS of three major psychiatric disorders to detect their common factor, further, to identify the loci associated with such as a common factor, and the locis transcription consequences in the brain. Propelled by the phenomenon \"genes do not read DSM\", we used a cutting-edge clustering algorithm to redefine three disorders based on the cerebral spatial expression pattern of associated core gene. Our study provides another piece of evidence as to the potentials of utilizing the signals arising from large population-scale GWAS to dissect and redefine psychiatric disorders.\n\nImplications of all the available evidenceConsistent with previous case-control cross-disorder GWAS, our study suggests that a common factor exists in three major psychiatric disorders and the biological information of core gene associated with the common factor could be used as an objective marker to explain three disorders and their pathophysiology.

genomics↗

Uncovering bi-directional causal relationships between plasma proteins and psychiatric disorders: A proteome-wide study leveraging GWAS summary data

Psychiatric disorders represent a major public health burden yet their etiologies remain poorly understood, and treatment advances are limited. In addition, there are no reliable biomarkers for diagnosis or progress monitoring. Here we performed a proteome-wide causal association study covering 3522 plasma proteins and 24 psychiatric traits or disorders, based on large-scale GWAS data and the principle of Mendelian randomization (MR). We have conducted ~95,000 MR analyses in total; to our knowledge, this is the most comprehensive study on the causal relationship between plasma proteins and psychiatric traits. The analysis was bi-directional: we studied how proteins may affect psychiatric disorder risks, but also looked into how psychiatric traits/disorders may be causal risk factors for changes in protein levels. We also performed a variety of additional analysis to prioritize protein-disease associations, including HEIDI test for distinguishing functional association from linkage, analysis restricted to cis- acting variants and replications in independent datasets from the UK Biobank. Based on the MR results, we constructed directed networks linking proteins, drugs and different psychiatric traits, hence shedding light on their complex relationships and drug repositioning opportunities. Interestingly, many top proteins were related to inflammation or immune functioning. The full results were also made available online in searchable databases. In conclusion, identifying proteins causal to disease development have important implications on drug discovery or repurposing. Findings from this study may also guide the development of blood-based biomarkers for the prediction or diagnosis of psychiatric disorders, as well as assessment of disease progression or recovery.

genomics↗

Jumping To Conclusions, General Intelligence, And Psychosis Liability: Findings From The Multicentric EU-GEI Case-Control Study

BackgroundThe \"jumping to conclusions\" (JTC) bias is associated with both psychosis and general cognition but their relationship is unclear. In this study, we set out to clarify the relationship between the JTC bias, IQ, psychosis and polygenic liability to schizophrenia and IQ.\n\nMethods817 FEP patients and 1294 population-based controls completed assessments of general intelligence (IQ), and JTC (assessed by the number of beads drawn on the probabilistic reasoning \"beads\" task) and provided blood or saliva samples from which we extracted DNA and computed polygenic risk scores for IQ and schizophrenia.\n\nResultsThe estimated proportion of the total effect of case/control differences on JTC mediated by IQ was 79%. Schizophrenia Polygenic Risk Score (SZ PRS) was non-significantly associated with a higher number of beads drawn (B= 0.47, 95% CI -0.21 to 1.16, p=0.17); whereas IQ PRS (B=0.51, 95% CI 0.25 to 0.76, p<0.001) significantly predicted the number of beads drawn, and was thus associated with reduced JTC bias. The JTC was more strongly associated with higher level of psychotic-like experiences (PLE) in controls, including after controlling for IQ (B= -1.7, 95% CI -2.8 to -0.5, p=0.006), but did not relate to delusions in patients.\n\nConclusionsthe JTC reasoning bias in psychosis is not a specific cognitive deficit but is rather a manifestation or consequence, of general cognitive impairment. Whereas, in the general population, the JTC bias is related to psychotic-like experiences, independent of IQ. The work has potential to inform interventions targeting cognitive biases in early psychosis.

neuroscience↗

LFMD: a new likelihood-based method to detect low-frequency mutations without molecular tags

As next-generation sequencing (NGS) and liquid biopsy become more prevalent in research and in the clinic, there is an increasing need for better methods to reduce cost and improve sensitivity and specificity of low-frequency mutation detection (where the Alternative Allele Frequency, or AAF, is less than 1%). Here we propose a likelihood-based approach, called Low-Frequency Mutation Detector (LFMD), which combines the advantages of duplex sequencing (DS) and the bottleneck sequencing system (BotSeqS) to maximize the utilization of duplicate reads. Compared with the existing state-of-the-art methods, DS, Du Novo, UMI-tools, and Unified Consensus Maker, our method achieves higher sensitivity, higher specificity (< 4 x 10-10 errors per base sequenced) and lower cost (reduced by ~70% at best) without involving additional experimental steps, customized adapters or molecular tags. LFMD is useful in areas where high precision is required, such as drug resistance prediction and cancer screening. As an example of LFMDs applications, mitochondrial heterogeneity analysis of 28 human brain samples across different stages of Alzheimers Disease (AD) showed that the canonical oxidative damage related mutations, C:G>A:T, are significantly increased in the mid-stage group. This is consistent with the Mitochondrial Free Radical Theory of Aging, suggesting that AD may be linked to the aging of brain cells induced by oxidative damage.

bioinformatics↗

Whole genome base-wise aggregation and functional prediction for human non-coding regulatory variants

Predicting the functional or pathogenic regulatory variants in the human non-coding genome facilitates the interpretation of disease causation. While numerous prediction methods are available, their performance is inconsistent or restricted to specific tasks, which raises the demand of developing comprehensive integration for those methods. Here, we compile whole genome base-wise aggregations, regBase, that incorporate largest prediction scores. Building on different assumptions of causality, we train three composite models to score functional, pathogenic and cancer driver non-coding regulatory variants respectively. We demonstrate the superior and stable performance of our models using independent benchmarks and show great success to fine-map causal regulatory variants. We believe that regBase database together with three composite models will be useful in different areas of human genetic studies, such as annotation-based casual variant fine-mapping, pathogenic variant discovery as well as cancer driver mutation identification. regBase is freely available at https://github.com/mulinlab/regBase.

genomics↗